Evidence map›Paper›PMID 36016530›Full record

ArticleHeliyon2022

Molecular docking and

Mitat Akkoç, Siraj Khan, Hande Yüce, Neşe Başak Türkmen, Şeyma Yaşar, Sedat Yaşar, İsmail Özdemir

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Silver(I) Complexes Based on Oxadiazole-FunctionalizedMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mitat AkkoçMalatya Turgut Özal University, Hekimhan Vocational College, Department of Property Protection and Security, Hekimhan, Malatya, Turkey.
Siraj KhanQuaid-i-Azam University, Faculty of Biological Sciences, Department of Pharmacy, Islamabad, 45320, Pakistan.
Hande Yüceİnönü University, Faculty of Pharmacy, Department of pharmaceutical toxicology, 44280 Malatya, Turkey.
Neşe Başak Türkmenİnönü University, Faculty of Pharmacy, Department of pharmaceutical toxicology, 44280 Malatya, Turkey.
Şeyma YaşarInönü University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, 44280 Malatya, Turkey.
Sedat Yaşarİnönü University, Faculty of Science and Arts, Department of Chemistry, 44280 Malatya, Turkey.
İsmail Özdemirİnönü University, Faculty of Science and Arts, Department of Chemistry, 44280 Malatya, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of symmetric and unsymmetrical benzimidazolium-based N-heterocyclic carbene (NHC) precursors (

Indexed as

Anticancer activityBreast cancer cell line (MCF-7)Healthy fibroblast cell line (L929)Neuroblastoma cell line (SH-SY5Y)Silver-N-heterocyclic carbene

Identifiers

PMID36016530
PMCPMC9396551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.